Nordic Pharma, a subsidiary of Nordic Group B.V., announced a partnership with Harrow, a leading North American eyecare company, to launch an authorized generic of Maxitrol (neomycin and polymyxin B ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The new drug application transfer process for Iopidine 1 ...

Harrow Health, Inc. (NASDAQ: HROW) revealed that it has acquired the exclusive U.S. commercialization rights to four FDA-approved branded eye drops from Novartis (NYSE:NVS) for a one‑time payment of ...

NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced its acquisition of the exclusive U.S. commercialization rights of four ...